The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
Index/HR/HR Benecast
HR Benecast artwork

Ep. 5 - Claim Adjudication and Reconciliation: Key Concepts Plan Sponsors Should Know

HR Benecast · 2026-07-01 · 8 min

0:00--:--

Key moments - from our scoring

Substance score

45 / 100

Five dimensions, 20 points each

Insight Density10 / 20
Originality8 / 20
Guest Caliber9 / 20
Specificity & Evidence11 / 20
Conversational Craft7 / 20

Claim adjudication and reconciliation are distinct processes that directly impact what plan sponsors actually pay for pharmacy benefits - yet many confuse them. Adjudication is the price at which a claim processes at the pharmacy counter, typically based on the lowest of three benchmarks: maximum allowable cost (MAC), discounted cost, or usual and customary (UNC) price. Reconciliation, by contrast, is an end-of-year true-up ensuring claims meet guaranteed rates or discounts, regardless of point-of-sale prices. Madison and Mike explore how recent regulatory mandates - the CAA 2026 pass-through requirements and FTC settlements - affect these mechanics differently: rebate pass-through at point of sale relates to adjudication, while 100% rebate pass-through relates to reconciliation. They also unpack how PBM models like CVS's TrueCost set unit prices by GPI-14 that represent reconciliation guarantees, not point-of-sale prices. For employers and plan sponsors, understanding this distinction is critical for accurate budgeting, cash flow forecasting, and comparing PBM proposals.

Key takeaways

  • →Claim adjudication determines the point-of-sale price using the lowest of three benchmarks (MAC, discounted cost, or UNC price), while reconciliation guarantees an overall average price regardless of individual claim prices.
  • →PBM true-cost models set unit prices reconciled at year-end rather than at the point of sale, so unit prices published by GPI-14 don't reflect actual counter prices.
  • →CAA 2026 and FTC settlements define rebates differently, creating confusion that rulemaking will need to clarify for consistent implementation across federal and state levels.
  • →Plan sponsors must understand whether they're paying at adjudication versus reconciliation to accurately budget cash flow and evaluate PBM contract terms.
  • →True-up mechanisms for discount and rebate reconciliation already exist in current PBM contracts and will continue under new pricing models.

In this episode

  1. 1Understanding Claim Adjudication vs. Reconciliation
  2. 2PBM Pricing Benchmarks and Lowest of Logic
  3. 3End-of-Year Reconciliation and Effective Rate Guarantees
  4. 4CAA 2026 and FTC Settlement Requirements
  5. 5CVS True Cost Model and Reconciliation Guarantees
  6. 6Rebate Definitions and State-Level Variations
  7. 7Importance for Employers and Plan Sponsors

Mentioned

CVSFederal Trade CommissionBenefits BitesCAA 2026MadisonMike

Guests

Mike

Topics in this episode

Claim adjudicationClaim reconciliationMaximum Allowable Cost (MAC)Usual and Customary (UNC) pricingLowest of logicOverall effective rate guaranteeRebate pass-through requirementsCAA 2026FTC settlementsCVS true cost model

Questions this episode answers

What is the difference between claim adjudication and claim reconciliation?

Claim adjudication is the price at which a claim processes at the pharmacy counter, based on the lowest of MAC, discounted cost, or UNC price. Claim reconciliation is an end-of-year true-up that ensures claims meet a guaranteed overall rate or discount, regardless of the adjudication price.

How do CAA 2026 pass-through requirements differ from FTC settlement requirements for rebates?

CAA 2026 requires 100% rebate pass-through to plan sponsors (rebate reconciliation), while FTC settlements require rebates to be passed through at point of sale (rebate adjudication) to benefit participants - two different mechanisms with different impacts.

What does CVS TrueCost's unit price guarantee actually mean for plan sponsors?

TrueCost unit prices set by GPI-14 are reconciliation guarantees representing the average price paid over a year, not the actual price participants pay at the counter, so they don't indicate point-of-sale costs.

Why is understanding adjudication versus reconciliation important for plan sponsors comparing PBM offers?

Understanding the difference helps employers predict what they'll pay at the point of sale versus what the PBM guarantees, enabling better budget forecasting, cash flow management, and accurate comparison of competing PBM proposals.

How do PBM true-ups work under current and new PBM models?

True-ups are reconciliation mechanisms that adjust final payments if actual claims don't meet guaranteed rates; they exist in both traditional discount models and new models like TrueCost and aren't being eliminated by regulatory changes.

What our scoring noted

Our reviewer’s read on each dimension, with quotes from the episode.

Insight Density

10 / 20

The episode efficiently covers foundational PBM concepts (adjudication vs. reconciliation, MAC/UNC/lowest-of logic, true-up mechanics) and ties them to current regulatory developments in 8 minutes - reasonable density for the runtime. However, the insights are definitional and introductory rather than novel; an experienced benefits consultant or PBM analyst would gain little new here.

anytime you hear overall effective rate, you think average, you think reconciliation
how the FTC has defined rebates, at least in the ESI settlement, how the CAA is defining rebates are different

Originality

8 / 20

Most of the episode is straightforward definitional content that any PBM primer would cover. The one modestly fresh observation - that the FTC, CAA, and various states are using different definitions of 'rebates,' creating regulatory fragmentation - is timely and underappreciated, but it is only briefly touched on rather than developed into an original argument.

how the FTC has defined rebates, at least in the ESI settlement, how the CAA is defining rebates are different
different states may have rebate pass requirements that have different definition of rebates Florida versus Illinois

Guest Caliber

9 / 20

Mike demonstrates solid practitioner-level fluency with PBM contract mechanics, current regulatory developments (CAA 2026, FTC/ESI settlement), and real-world client concerns like cash flow and budgeting, suggesting genuine consulting experience. No credentials or firm are named, and there is no indication of scale or seniority, preventing a higher score.

cash flow is super important to most of our clients
We have that today in PBM contracts. We see discount reconciliation true ups. We see rebate true ups

Specificity & Evidence

11 / 20

The episode earns credit for naming specific pricing benchmarks (MAC, UNC), regulatory instruments (CAA 2026, FTC/ESI settlement), a real PBM model (CVS True Cost), a specific pricing unit (GPI-14), and state-level contracting differences (Florida vs. Illinois). However, there are no hard numbers - no actual discount percentages, dollar figures, or client-level data - which limits how actionable the specifics are.

PBMs have to pass through 100% of rebates to plan sponsors
CVS true cost model true cost sets a unit price And for brands that unit price is net of rebates And some folks as they taken a look at these unit prices

Conversational Craft

7 / 20

The co-host format is clearly scripted, with Madison serving primarily as a setup prompt rather than a genuine interlocutor - questions like 'Is there an easy way for us to remember?' and the formulaic 'bottom line it for me' closer are structural cues rather than probing follow-ups. There is no pushback, no challenging of ambiguous claims, and no moments of productive tension.

Well, that sounds very technical, Mike. Is there an easy way for us to remember the difference
Is that a fair summary?

Conversation analysis

Computed from the transcript - who did the talking, and the words that came up most.

Most-used words

price13claim10reconciliation10adjudication9rebates9true8claims6generic6mike5overall5different5cost5discount5rebate5unit5today4

Episode notes

Claim adjudication and claim reconciliation are critical - but often misunderstood - components of pharmacy benefit management. In this episode of Benefits Bites, Mike and Madison break down how these processes work, why they matter for plan sponsors and how recent legislative and regulatory changes are reshaping rebate and price guarantee requirements. Register for upcoming Employers Health webinars or watch on demand at

Full transcript

8 min

Transcribed and scored by The B2B Podcast Index.

Good afternoon. I'm Madison. This is Mike. And welcome to another episode of Benefits Bites, where we break down complex employee benefits topics into bite-sized updates.

Short bite-sized updates. Short, yep. What are we talking about today, Mike? Yeah, I think with all the legislative and regulatory events going on and requirements hitting the marketplace, I thought it would be good to tackle a really exciting topic on what the difference is between claim adjudication and claim reconciliation.

Well, that sounds very technical, Mike. Is there an easy way for us to remember the difference between adjudication and reconciliation? Well, I think it's in the names. So claim adjudication is what the price is at the time that a claim is actually filled and processed at the pharmacy.

And claim reconciliation is you take that claim and understand if there is a guarantee that that claim and other claims that are similar to it are reconciled to. So think of generic drugs in terms of we reconcile generics to an overall guarantee. So can you walk us through an example of how this plays out in standard PBM pricing? Yeah, so I use generics as an example.

We'll just keep going with that. But when we think about generic adjudication, what price do generic claims actually process at at the pharmacy counter? And it's typically one of a few different pricing benchmarks. So it could be the maximum allowable cost or MAC.

It could be the discounted cost or it could be the pharmacy usual and customary price usually called the UNC price So from an adjudication perspective it typically the lowest of those three benchmarks You hear that defined as or called lowest of logic. So that's claim adjudication. Then at the end of the year, typically it's at the end of the year. It could be a different time period, but typically it's 12 months.

the PBM will set an overall effective guarantee or an overall effective rate guarantee. And anytime you hear overall effective rate, you think average, you think reconciliation. So that particular generic claim, along with all generic claims, say, in the retail setting, dispensed at a 30-day supply, are reconciled towards that guaranteed discount. So again, regardless of what price it actually processed at, we'll look at that price.

We'll look at the average wholesale price. We'll calculate the discount of that claim and all claims in that bucket and see if it hit the discount. If it didn't, guess what? PBM has to true up.

So when we think about tying this into the recent regulatory developments that you mentioned, let's take the CAA 2026 pass-through requirements. So PBMs have to pass through 100% of rebates to plan sponsors. That refers to the rebate reconciliation. Whereas whenever we think about the Federal Trade Commission settlements, there are some provisions in there that say that rebates have to be passed through at the point of sale, which would relate to adjudication.

Is that a fair summary? That's exactly right. So I like how you switched from discount guarantees to rebate guarantees because it does, it applies to both. So I think that the PBMs certainly in their new models are presenting both types of guarantees.

So if we think about CVS true cost model true cost sets a unit price And for brands that unit price is net of rebates And some folks as they taken a look at these unit prices I should say that they set by GPI 14s But as they look at those unit prices, they think, oh, that's what I'm going to pay now at the counter. And that's not accurate. So for true costs, those are reconciliation guarantees. It doesn't necessarily tell us what the price is actually going to be at the point of sale.

It just says that at the end of the year, we're going to take all brand claims for that particular product or all generic claims for that particular product or that particular GPI-14, and we're going to make sure that overall our average unit price that we paid was X amount. So that's how true cost works. I think from a rebate perspective, all we know is that from a reconciliation perspective, as you said, we have to reconcile to 100% of rebates. The FTC tells us that some portion of those rebates have to be applied at the point of sale so that it benefits participants.

I think as we take one more step into the cloud of confusion that surrounds all of this legislative and regulatory action that's out there, that how the FTC has defined rebates, at least in the ESI settlement, how the CAA is defining rebates are different. So we would hope that through the rulemaking process of the CAA, future FTC releases, that there's some type of similarity in terms of how rebates are defined. We already see a little bit of this confusion at the state level as well.

So different states may have rebate pass requirements that have different definition of rebates Florida versus Illinois and that may be why you have a state addendum at the end of your contract So that be interesting to see as well how that relates to the federal implementation over the next few years As always, at the end of these episodes, I ask you to bottom line it for me, Mike. Why is this important for employers and plan sponsors? Yeah, two reasons. I think the first is just understanding what you're going to pay and when you're going to pay it, understanding the difference between, you know, the price that's paid at adjudication versus the price that's guaranteed through reconciliation.

Helps you better understand how your PBM is going to perform. It also helps you when comparing one PBM offer to another. The second one is budgeting. So again, cash flow is super important to most of our clients.

And so they want to know what am I going to pay at the point of sale? And what ultimately is the PBM being held accountable to? And then how do those true ups work. That's not new.

We have that today in PBM contracts. We see discount reconciliation true ups. We see rebate true ups. So it's something that we have today.

It's something that these new models aren't necessarily going to cure for. And so we have to be ready and we have to understand how the payments will work under these new models. Well, great, Mike. I think that that may have been our most bite-sized update to date.

And probably the most fun. So, yeah, I sure have fun. Who doesn't like a good conversation about adjudication and reconciliation? Well, thanks so much for joining us today.

We'll see you next time.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

  • Opening Retail Stores vs. Going Wholesale: What the Numbers SayOperators · features Mike86 / 100
  • ERP130 - Project Delays and Failures, Breaking the CycleEvolved Radio · features Mike85 / 100
  • Current Trends in Restructuring : A fireside chat from the 2026 Distressed Investing SummitM&A Advisor Podcast · features Mike78 / 100
  • Nerds to Norms: Why real conversations still beat synthetic data in B2B product managementPractical Product Management · features Mike72 / 100
  • So What...? Are Industry Awards Worth It?It's not all about the numbers! · features Mike62 / 100
  • Season 3, Episode 10: Consumer Perception of Sustainable PackagingCrazy About Packaging: Conversations with the C.A.P. Pack · features Mike57 / 100

More from HR Benecast

All episodes →
  • Ep. 6 - The CVS and FTC Settlement: What it Means for Plan Sponsors80 / 100
  • Episode 64 - How Bath & Body Works Approaches Open Enrollment for a Large Workforce
  • Episode 63 - Zerigo Health and At-Home Phototherapy: Better Chronic Skin Condition Outcomes at a Lower Cost
  • Ep. 5 - TrumpRx Expansion, FTC Pressure and the Growing Push for PBM Transparency
  • Episode 62 - A Conversation with the 2026 Employers Health Excellence in Benefits Award Winner
Explore the best B2B HR podcasts →
All HR Benecast episodes →